These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

376 related items for PubMed ID: 27835819

  • 21. The use of direct oral anticoagulants in 56 patients with antiphospholipid syndrome.
    Malec K, Góralczyk T, Undas A.
    Thromb Res; 2017 Apr; 152():93-97. PubMed ID: 27989533
    [Abstract] [Full Text] [Related]

  • 22. Using new oral anticoagulants in patients undergoing major orthopedic surgery.
    Bass AR.
    Curr Rheumatol Rep; 2015 Apr; 17(4):25. PubMed ID: 25854486
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Emergency Coagulation Assessment During Treatment With Direct Oral Anticoagulants: Limitations and Solutions.
    Ebner M, Birschmann I, Peter A, Härtig F, Spencer C, Kuhn J, Blumenstock G, Zuern CS, Ziemann U, Poli S.
    Stroke; 2017 Sep; 48(9):2457-2463. PubMed ID: 28775134
    [Abstract] [Full Text] [Related]

  • 26. Optimizing the safety of treatment for venous thromboembolism in the era of direct oral anticoagulants.
    Weitz JI, Jaffer IH.
    Pol Arch Med Wewn; 2016 Sep 05; 126(9):688-696. PubMed ID: 27592622
    [Abstract] [Full Text] [Related]

  • 27. Are Screening Tests Reliable to Rule Out Direct Oral Anticoagulant Plasma Levels at Various Thresholds (30, 50, or 100 ng/mL) in Emergency Situations?
    Jabet A, Stepanian A, Golmard JL, Flaujac C, Joly BS, Gouin-Thibault I, Siguret V.
    Chest; 2018 Jan 05; 153(1):288-290. PubMed ID: 29307427
    [No Abstract] [Full Text] [Related]

  • 28. Replacing warfarin therapy with the newer direct oral anticoagulants, or simply a growth in anticoagulation therapy? Implications for pathology testing.
    Favaloro EJ, Pasalic L, Lippi G.
    Pathology; 2017 Oct 05; 49(6):639-643. PubMed ID: 28826832
    [No Abstract] [Full Text] [Related]

  • 29. Is it reasonable to use a lower DOACs dose in some patients with VTE? Yes.
    Imberti D, Mastroiacovo D.
    Intern Emerg Med; 2017 Aug 05; 12(5):561-563. PubMed ID: 28647891
    [Abstract] [Full Text] [Related]

  • 30. Comparison of the Efficacy and Safety of Direct Oral Anticoagulants and Warfarin After Bioprosthetic Valve Replacements.
    Pasciolla S, Zizza LF, Le T, Wright K.
    Clin Drug Investig; 2020 Sep 05; 40(9):839-845. PubMed ID: 32607688
    [Abstract] [Full Text] [Related]

  • 31. Novel (Oral) Anticoagulant Challenges in Surgery.
    Blennerhassett R, Favaloro EJ, Pasalic L.
    Semin Thromb Hemost; 2017 Oct 05; 43(7):706-715. PubMed ID: 28597459
    [No Abstract] [Full Text] [Related]

  • 32. Assessment of direct oral anticoagulant assay use in clinical practice.
    Gu TM, Garcia DA, Sabath DE.
    J Thromb Thrombolysis; 2019 Apr 05; 47(3):403-408. PubMed ID: 30600427
    [Abstract] [Full Text] [Related]

  • 33. Interlaboratory variability in the measurement of direct oral anticoagulants: results from the external quality assessment scheme.
    Tripodi A, Chantarangkul V, Legnani C, Testa S, Tosetto A.
    J Thromb Haemost; 2018 Mar 05; 16(3):565-570. PubMed ID: 29322630
    [Abstract] [Full Text] [Related]

  • 34. Point-of-care testing for emergency assessment of coagulation in patients treated with direct oral anticoagulants.
    Ebner M, Birschmann I, Peter A, Spencer C, Härtig F, Kuhn J, Blumenstock G, Zuern CS, Ziemann U, Poli S.
    Crit Care; 2017 Feb 15; 21(1):32. PubMed ID: 28196509
    [Abstract] [Full Text] [Related]

  • 35. Appropriateness of non-vitamin K antagonist oral anticoagulant dose in patients with atrial fibrillation in Israel: A population-based study.
    Ellis MH, Dotan SG, Hammerman A, Battat E, Derazne E, Avnery O.
    Thromb Res; 2018 Sep 15; 169():140-142. PubMed ID: 30056294
    [No Abstract] [Full Text] [Related]

  • 36. Performance of direct oral anticoagulant (DOAC) testing by hemostasis laboratories: The Australasian/Asia-Pacific experience.
    Favaloro EJ, Arunachalam S, Dean E.
    Int J Lab Hematol; 2024 Aug 15; 46(4):731-740. PubMed ID: 38644463
    [Abstract] [Full Text] [Related]

  • 37. A single test to assay warfarin, dabigatran, rivaroxaban, apixaban, unfractionated heparin, and enoxaparin in plasma.
    Letertre LR, Gudmundsdottir BR, Francis CW, Gosselin RC, Skeppholm M, Malmstrom RE, Moll S, Hawes E, Francart S, Onundarson PT.
    J Thromb Haemost; 2016 May 15; 14(5):1043-53. PubMed ID: 26924677
    [Abstract] [Full Text] [Related]

  • 38. A simple and fast HPLC-MS/MS method for simultaneous determination of direct oral anticoagulants apixaban, dabigatran, rivaroxaban in human plasma.
    Lagoutte-Renosi J, Le Poupon J, Girard A, Montange D, Davani S.
    J Chromatogr B Analyt Technol Biomed Life Sci; 2018 Nov 15; 1100-1101():43-49. PubMed ID: 30292948
    [Abstract] [Full Text] [Related]

  • 39. Pharmacokinetics of anticoagulants apixaban, dabigatran, edoxaban and rivaroxaban in elderly Japanese patients with atrial fibrillation treated in one general hospital.
    Yamazaki-Nishioka M, Kogiku M, Noda M, Endo S, Takekawa M, Kishi H, Ota M, Notsu Y, Shimizu M, Yamazaki H.
    Xenobiotica; 2019 Sep 15; 49(9):1001-1006. PubMed ID: 30216091
    [Abstract] [Full Text] [Related]

  • 40. National Trends in Ambulatory Oral Anticoagulant Use.
    Barnes GD, Lucas E, Alexander GC, Goldberger ZD.
    Am J Med; 2015 Dec 15; 128(12):1300-5.e2. PubMed ID: 26144101
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 19.